Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
ExCellThera Inc. ("ExCellThera"), a global leader in blood stem cell expansion and metabolic fitness technologies and parent ...
In the wake of the Food & Drug Administration’s (FDA) ambitious unified agenda, on July 13, 2026, the agency published a proposed rule aiming to ...
Dive Into an AI Future] In acquisition news, Broadcast Solutions GmbH, a systems integrator and provider of innovative ...
For retailers, the challenge is no longer simply managing tobacco, it is actively rebalancing shelves behind the counter that ...
Malaria in pregnancy (MiP) is a significant public health concern in high-burden malaria countries and a key predictor of ...
Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
The Amazing Times on MSN
Foreign substance leads to nearly 1 million bottles of heart and kidney medication recalled
Nearly 1 million bottles of heart and kidney medications were recalled over foreign substances found on tablets. The post ...
Detailed price information for Precision Peptide Company Inc (BPC-CN) from The Globe and Mail including charting and trades.
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results